"We are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the US and Canada," says Moderna CEOfrom GEO TV - Entertainment https://ift.tt/3vtyO0J
"We are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the US and Canada," says Moderna CEO
0 Comments